Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
書誌事項
- 公開日
- 2015-08
- 権利情報
-
- http://creativecommons.org/licenses/by-nc/3.0/
- DOI
-
- 10.2147/dddt.s86621
- 公開者
- Informa UK Limited
収録刊行物
-
- Drug Design, Development and Therapy
-
Drug Design, Development and Therapy 9 4479-, 2015-08
Informa UK Limited